BACKGROUND: Moderate physical activity is associated with an improved prognosis and psychosocial outcome in breast cancer patients. Although exercise and physical activity are associated with multiple physiological and psychological effects, many of the underlying mechanisms remain obscure. The BEGYN study (Influence of physical activity in breast cancer patients on physiological and psychological parameters and on biomarkers) aims at identifying potential associations between the extent of physical activity, fitness, body composition, immunological biomarkers, psycho-emotional parameters, and the course of treatment during the first year after diagnosis of breast cancer. METHODS: The prospective observational BEGYN study will include 110 non-metastatic breast cancer patients. The patients will be assessed during a base line visit prior to the initiation of the antineoplastic therapy and after 3, 6, 9 and 12 months. The physical activity will be measured using a fitness tracker and a self-assessment diary during the entire study. Each visit will include the assessment of (i) cardiorespiratory fitness measured by spiroergometry, (ii) body composition, (iii) psycho-emotional parameters (quality of life, mental health, fatigue, depression, distress, anxiety, well-being), and (iv) extensive blood tests including routine laboratory, vitamin D, selenium and immunologically relevant biomarkers (e.g., leukocyte subpopulations and cytokine profiles). DISCUSSION: Whereas most studies investigating the influence of physical activity in breast cancer patients focus on specific activities for three months or less, the BEGYN study will quantify the daily physical activity and cardiorespiratory fitness of breast cancer patients based on objective measurements in the context of the oncological therapy for 12 months after diagnosis. The study will reveal potential associations between exercise, immune status and physical as well as psycho-emotional outcome and the clinical course of the disease. Moreover, complementary therapies such as Vit D and Selenium supplementation and parameters investigating the motivation of the patients are part of the study. Due to this holistic approach, the BEGYN study will guide towards confirmatory studies on the role of physical activity in breast cancer patients to develop individualized counselling regarding the recommended type and extent of exercise. TRIAL REGISTRATION: This study has been registered at the German Clinical Trials Register DRKS00024829.
BACKGROUND: Moderate physical activity is associated with an improved prognosis and psychosocial outcome in breast cancer patients. Although exercise and physical activity are associated with multiple physiological and psychological effects, many of the underlying mechanisms remain obscure. The BEGYN study (Influence of physical activity in breast cancer patients on physiological and psychological parameters and on biomarkers) aims at identifying potential associations between the extent of physical activity, fitness, body composition, immunological biomarkers, psycho-emotional parameters, and the course of treatment during the first year after diagnosis of breast cancer. METHODS: The prospective observational BEGYN study will include 110 non-metastatic breast cancer patients. The patients will be assessed during a base line visit prior to the initiation of the antineoplastic therapy and after 3, 6, 9 and 12 months. The physical activity will be measured using a fitness tracker and a self-assessment diary during the entire study. Each visit will include the assessment of (i) cardiorespiratory fitness measured by spiroergometry, (ii) body composition, (iii) psycho-emotional parameters (quality of life, mental health, fatigue, depression, distress, anxiety, well-being), and (iv) extensive blood tests including routine laboratory, vitamin D, selenium and immunologically relevant biomarkers (e.g., leukocyte subpopulations and cytokine profiles). DISCUSSION: Whereas most studies investigating the influence of physical activity in breast cancer patients focus on specific activities for three months or less, the BEGYN study will quantify the daily physical activity and cardiorespiratory fitness of breast cancer patients based on objective measurements in the context of the oncological therapy for 12 months after diagnosis. The study will reveal potential associations between exercise, immune status and physical as well as psycho-emotional outcome and the clinical course of the disease. Moreover, complementary therapies such as Vit D and Selenium supplementation and parameters investigating the motivation of the patients are part of the study. Due to this holistic approach, the BEGYN study will guide towards confirmatory studies on the role of physical activity in breast cancer patients to develop individualized counselling regarding the recommended type and extent of exercise. TRIAL REGISTRATION: This study has been registered at the German Clinical Trials Register DRKS00024829.
Authors: Kathryn H Schmitz; Rehana L Ahmed; Andrea Troxel; Andrea Cheville; Rebecca Smith; Lorita Lewis-Grant; Cathy J Bryan; Catherine T Williams-Smith; Quincy P Greene Journal: N Engl J Med Date: 2009-08-13 Impact factor: 91.245
Authors: Iris J G Ketel; Mariken N M Volman; Jacob C Seidell; Coen D A Stehouwer; Jos W Twisk; Cornelis B Lambalk Journal: Eur J Endocrinol Date: 2007-06 Impact factor: 6.664
Authors: J Uth; B Fristrup; R D Haahr; K Brasso; J W Helge; M Rørth; J Midtgaard; E W Helge; P Krustrup Journal: Scand J Med Sci Sports Date: 2018-07-12 Impact factor: 4.221
Authors: Stephanie Skender; Jennifer Ose; Jenny Chang-Claude; Michael Paskow; Boris Brühmann; Erin M Siegel; Karen Steindorf; Cornelia M Ulrich Journal: BMC Public Health Date: 2016-06-16 Impact factor: 3.295
Authors: Jean-Sébastien Souweine; Nils Kuster; Leila Chenine; Annie Rodriguez; Laure Patrier; Marion Morena; Eric Badia; Lotfi Chalabi; Nathalie Raynal; Isabelle Ohresser; Helene Leray-Moragues; Jacques Mercier; Maurice Hayot; Moglie Le Quintrec; Fares Gouzi; Jean-Paul Cristol Journal: PLoS One Date: 2018-08-01 Impact factor: 3.240